Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 000893.SZ
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Weak
17%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 4.80 0.68 0.64
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 2226.61 14.37 0.62
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.66 12.38 12.30
Cash -25.21 0.62 0.83
Capex -11.20 -0.89 -0.80
Free Cash Flow -123.76 -0.97 -0.43
Revenue -39.77 0.61 1.01
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -3.06 0.47 0.48
Operating Margin -58.58 0.16 0.38
ROA -67.76 < 0.005 0.02
ROE -66.46 < 0.005 0.02
ROIC -72.77 < 0.005 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 000893.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 000893.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 000893.SZ is permitted for members.